News

Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has announced the expansion of its international commercial operations.

Researchers have found that stem cell function can be enhanced through manipulation of their culture environment, and that "priming" prior to patient administration could optimize their therapeutic potential.

Researchers have discovered why men are much less likely to develop multiple sclerosis (MS) — high levels of testosterone. Testosterone triggers production of the cytokine IL-33 protecting them from the disease.

A new report highlights the serious environmental and human health impacts caused by uncontrolled manufacturing discharges from pharmaceutical factories in Hyderabad, India. These factories in Hyderabad constitute one of the world’s largest generic drug manufacturing hubs.

A new source of the botulinum neurotoxin was discovered by Canadian and American scientists in a strain of animal gut bacteria known as Enterococcus faecium. "Its discovery has implications in several fields, from monitoring the emergence of new pathogens to the development of new protein therapeutics--it's a game changer."

The acquisition of Selcia provides Eurofins with an entry into the custom radiolabelling and innovative pre-clinical, integrated drug discovery services markets.

Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines.

Researchers at Oregon State University have taken an important step toward a more convenient, less expensive means of preserving mammalian cells for in vitro fertilization, species conservation, cell therapy and other purposes.

Oral rotavirus vaccine, ROTAVAC®, will now be available for procurement by United Nations agencies and Gavi, the Vaccine Alliance, for use in low-resource countries

Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK. Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments.